Ionis Pharmaceuticals, Inc. logo

Ionis Pharmaceuticals, Inc. (IONS)

Market Closed
15 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
79. 77
-1.05
-1.3%
Pre Market
$
81. 62
+1.85 +2.32%
13.14B Market Cap
- P/E Ratio
0% Div Yield
1,664,528 Volume
-3.43 Eps
$ 80.82
Previous Close
Day Range
79.31 81
Year Range
23.95 83.61
Want to track IONS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 64 days
Ionis (IONS), Biogen Down on Ending Development of ALS Drug

Ionis (IONS), Biogen Down on Ending Development of ALS Drug

Ionis (IONS) and Biogen (BIIB) stop developing their experimental ALS drug after a phase I/II study failed to show improvement in patients.

Zacks | 1 year ago